Showing results (21-30 of 120) with videos related to
Sort By:
Pageof 12
British Journal of Cancer|June 1, 1993
Pharmacokinetic studies in mice with ICI D0490, a novel recombinant ricin A-chain immunotoxinJ A Calvete, D R Newell, C J Charlton, et al.British Journal of Cancer|January 1, 1983
Pentamethylmelamine (PMM): Phase I clinical and pharmacokinetic studiesJ R Muindi, D R Newell, I E Smith, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 13, 2001
The impact of p53 status on cellular sensitivity to antifolate drugsX Lu, J Errington, N J Curtin, et al.Biochemical Pharmacology|November 1, 1986
The effect of the nucleoside transport inhibitor dipyridamole on the incorporation of [3H]thymidine in the ratD R Newell, P M O'Connor, A H Calvert, et al.Cancer Chemotherapy and Pharmacology|January 1, 1989
The pharmacokinetics and toxicity of the anthrapyrazole anti-cancer drug CI-941 in the mouse: a guide for rational dose escalation in patientsM A Graham, D R Newell, B J Foster, et al.British Journal of Cancer|January 5, 2001
Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitroK J Bowman, D R Newell, A H Calvert, et al.Cancer Research|September 1, 1994
In vitro and in vivo antitumor activity of ZENECA ZD0490, a recombinant ricin A-chain immunotoxin for the treatment of colorectal cancerJ A Calvete, D R Newell, A F Wright, et al.Cancer Chemotherapy and Pharmacology|January 1, 1982
The comparative pharmacokinetics of pentamethylmelamine in man, rat, and mouseC J Rutty, D R Newell, J R Muindi, et al.British Journal of Clinical Pharmacology|February 1, 1983
Studies on the pharmacokinetics of chlorambucil and prednimustine in manD R Newell, A H Calvert, K R Harrap, et al.Biochemical Pharmacology|June 15, 1987
The comparative pharmacokinetics of carboplatin and cisplatin in mice and ratsZ H Siddik, D R Newell, F E Boxall, et al.Pageof 12